Skip to main content

Animations

MJFF Publications

5311 - 5320 of 6082 Results
Title
Year
  • Year
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • 2014
  • Summary Details
    OPEN
    Title: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1038/mt.2014.129
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study
    Journal Name: Journal of Neurophysiology
    Publisher: American Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1152/jn.00383.2014
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.004
    Citation Count: 47
  • Summary Details
    OPEN
    Title: A Neurodegenerative Vascular Burden Index and the Impact on Cognition
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2014.00161
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1321785111
    Citation Count: 292
  • Summary Details
    OPEN
    Title: Noninvasive optical inhibition with a red-shifted microbial rhodopsin
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.3752
    Citation Count: 531
  • Summary Details
    OPEN
    Title: Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: A practical human model to study Alzheimer's disease vasculopathy
    Journal Name: Journal of Neuroscience Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jneumeth.2014.06.014
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awu179
    Citation Count: 180
  • Summary Details
    OPEN
    Title: Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0101453
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.06.018
    Citation Count: 46
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.